135 related articles for article (PubMed ID: 7387799)
41. [The changes and relation among platelet function, plasma heparin and anti-coagulation-III: activity in patients with hemorrhagic fever with renal syndrome].
Wei L; Pan X; Yu Y; Lu Q
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):163-5. PubMed ID: 15619827
[TBL] [Abstract][Full Text] [Related]
42. Preparation and anticoagulation activity of sodium cellulose sulfate.
Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY
Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735
[TBL] [Abstract][Full Text] [Related]
43. Protamine inhibits formation of the covalent factor IXa-anti-thrombin complex.
Brecher AS; Roland AR
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):591-6. PubMed ID: 18685444
[TBL] [Abstract][Full Text] [Related]
44. [A clinical evaluation of the Hepcon/HMS: a new device of monitoring hemostasis management during cardiopulmonary bypass].
Yamanishi H; Watanabe S; Hayashi K; Tomioka H; Minami M; Nozaki Y; Aoki T; Kawai Y; Kishino K; Ohta S
Kyobu Geka; 1997 Jun; 50(6):459-62. PubMed ID: 9185440
[TBL] [Abstract][Full Text] [Related]
45. Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfate.
Torjemane L; Guermazi S; Ladeb S; Ben Romdhane N; Lakhal A; Abdelkefi A; Ben Othman T; Ben Abdelhadhim A
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):279-81. PubMed ID: 17413766
[TBL] [Abstract][Full Text] [Related]
46. [Method for determination of the heparin cofactor in blood plasma].
Chumakov VN
Lab Delo; 1973; 9():523-5. PubMed ID: 4128697
[No Abstract] [Full Text] [Related]
47. [Blood clotting diagnosis with chromogenic substrates].
Róka L; Rasche H
Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
[No Abstract] [Full Text] [Related]
48. [Comparative evaluation of different methods of determination of heparin in blood and tolerance of plasma to heparin].
Kalanov PI
Lab Delo; 1968; 10():601-3. PubMed ID: 4184081
[No Abstract] [Full Text] [Related]
49. Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.
Fareed J; Messmore HL; Walenga JM; Bermes EW
Clin Chem; 1983 Feb; 29(2):225-36. PubMed ID: 6821923
[TBL] [Abstract][Full Text] [Related]
50. Heparin cofactor deficiency and instability as reflected by the 24-hour heparin clot inhibition test.
Koszewski BJ; Powell LW; Vahabzadeh H
Vasc Dis; 1968 Sep; 5(3):152-64. PubMed ID: 5676640
[No Abstract] [Full Text] [Related]
51. [Degradation of protamine and protamine-heparin complexes by proteolytic enzymes of blood serum and serum euglobulin fractions].
Roszkowska W; Worowski K; Ostrowska H
Acta Haematol Pol; 1984; 15(1-2):43-7. PubMed ID: 6516712
[No Abstract] [Full Text] [Related]
52. [Heparin activity before and after iodized salt-water balneotherapy with protamine sulfate index and coagulation time].
FORTUNA A
Arch Med Interna; 1959; 11():225-34. PubMed ID: 13824073
[No Abstract] [Full Text] [Related]
53. Comparative plasma heparin levels after subcutaneous administration of calcium and magnesium heparin.
Follea G; Trzeciak MC; Dechavanne M
Thromb Res; 1981 Jul 1-15; 23(1-2):33-9. PubMed ID: 7302920
[No Abstract] [Full Text] [Related]
54. A simple technique for the measurement of plasma heparin concentration during anticoagulant therapy.
Marder VJ
Thromb Diath Haemorrh; 1970 Oct; 24(1):230-9. PubMed ID: 5483963
[No Abstract] [Full Text] [Related]
55. [Determination of the content of antiheparin factor of thrombocytes in the plasma].
Lychev VG
Lab Delo; 1974; (12):730-2. PubMed ID: 4140962
[No Abstract] [Full Text] [Related]
56. Protamine sulfate titration for heparin activity in neonates with indwelling umbilical catheters.
Hall RT; Rhodes PG; Turner EA; Braun WJ
J Pediatr; 1976 Mar; 88(3):467-72. PubMed ID: 1245960
[TBL] [Abstract][Full Text] [Related]
57. Plasma and leukocyte antiheparin activity in acute experimental pancreatitis.
Prokopowicz J; Gabryelewicz A
Haematologia (Budap); 1973; 7(3):375-9. PubMed ID: 4790075
[No Abstract] [Full Text] [Related]
58. [Determination of activity of antithrombin III - heparin in blood].
Katsadze IuL; Kotovshchikova MA
Lab Delo; 1982; (4):232-4. PubMed ID: 6177911
[No Abstract] [Full Text] [Related]
59. [Heparin cofactor level in the initial stage of acute leukoses. Reduction of this factor by asparaginase].
Kolodie L; Leger J; Hollard D
Lyon Med; 1972 Dec; 228(19):685-90. PubMed ID: 4662035
[No Abstract] [Full Text] [Related]
60. Determination of factor X and heparin with chromogenic substrate.
Aiach M; Michaud A; Capron L; Fiessinger JN
Acta Chir Scand Suppl; 1982; 509():109-13. PubMed ID: 6962612
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
